�Mylan on Wednesday announced a deal with Indian drug divine Famy Care to build up and sell 22 generic oral prophylactic device products, the Pittsburgh Tribune-Review reports (Stouffer, Pittsburgh Tribune-Review, 8/7). Mylan plans to seek FDA approval for the products over the next few months and hopes to begin marketing them in 2010. Under the price of the deal, Mylan can sell other contraceptives in other markets, including Australia and Japan. Mylan did not disclose fiscal terms of the dispense (AP/Yahoo! News, 8/6).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free overhaul of the National Partnership for Women & Families, published by The Advisory Board Company.
� 2008 The Advisory Board Company. All rights reserved.
More info
